Finerenone Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with finerenone
O
- Ocella (drospirenone / ethinyl estradiol)
- octreotide
- Ocudox (doxycycline)
- Ogsiveo (nirogacestat)
- Ojemda (tovorafenib)
- Okebo (doxycycline)
- olmesartan
- olutasidenib
- omadacycline
- omaveloxolone
- ombitasvir / paritaprevir / ritonavir
- Omeclamox-Pak (amoxicillin / clarithromycin / omeprazole)
- Omnitrope (somatropin)
- Onmel (itraconazole)
- Onyda XR (clonidine)
- Opsumit (macitentan)
- Opsynvi (macitentan / tadalafil)
- Oracea (doxycycline)
- OraVerse (phentolamine)
- Oravig (miconazole)
- Oraxyl (doxycycline)
- Orbactiv (oritavancin)
- Orbivan (acetaminophen / butalbital / caffeine)
- Orbivan CF (acetaminophen / butalbital)
- Orenitram (treprostinil)
- Oretic (hydrochlorothiazide)
- Oreticyl 25 (deserpidine / hydrochlorothiazide)
- Oreticyl 50 (deserpidine / hydrochlorothiazide)
- Oreticyl Forte (deserpidine / hydrochlorothiazide)
- Orgaran (danaparoid)
- Oriahnn (elagolix / estradiol / norethindrone)
- Orilissa (elagolix)
- oritavancin
- Orkambi (ivacaftor / lumacaftor)
- Orladeyo (berotralstat)
- osilodrostat
- Osmitrol (mannitol)
- Oxbryta (voxelotor)
- oxcarbazepine
- Oxtellar XR (oxcarbazepine)
- oxytetracycline
- oxytetracycline / phenazopyridine / sulfamethizole
More about finerenone
- finerenone consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: aldosterone receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.